What if doctors were able to identify, with a simple blood test, when a patient’s cancer was starting to make a return? Or that a person’s disease was so well treated it would not return?

A new treatment strategy designed at Roswell Park Comprehensive Cancer Center aims to deliver a one-two punch to airway tumors that threaten a patient’s ability to breathe — and a phase 2 clinical trial will evaluate how well it works.